Outcome Comparison of High-Risk Native American Patients Who Did or Did Not Receive Monoclonal Antibody Treatment for COVID-19

COVID-19에 대한 단일 클론 항체 치료를 받았거나 받지 않은 고위험 아메리카 원주민 환자의 결과 비교

Published on 2021-09-212022-09-12
Journal: JAMA Network Open

[저자] Ryan M. Close, T. Shaifer Jones, Christopher Jentoft, James B. McAuley

[Category] SARS, 진단,

PMC URL [DOI] 10.1001/jamanetworkopen.2021.25866

[Article Type] Comparative Study

[Source] PMC

This quality improvement study compares outcomes among high-risk Native American patients who did or did not receive monoclonal antibody treatment for COVID-19.

All Keywords
【초록키워드】 COVID-19, monoclonal antibody, outcome, Patient, Quality improvement, monoclonal antibody treatment, receive, Native, 【제목키워드】 COVID-19, Native,

이 품질 개선 연구는 COVID-19에 대한 단일 클론 항체 치료를 받았거나 받지 않은 고위험 아메리카 원주민 환자의 결과를 비교합니다.